Lorillard
Comments on H.R. 4957 - - Proposed 'comprehensive Smoking Prevention Education Act of 810000'
Fields
- Author
- Aviado, D.M.
- Alias
- 03607771/03607790
- Type
- REPT, OTHER REPORT
- BIBL, BIBLIOGRAPHY
- Area
- LEGAL DEPT FILE ROOM
- Site
- N14
- Named Organization
- Natl Academy of Sciences
- Univ of Pa School of Medicine
- Who, World Health Org
- Clean Air Scientific Advisory Comm
- Epa, Environmental Protection Agency
- Named Person
- Albert
- Andres
- Auerbach
- Briscoe
- Burrows
- Camner
- Chanyueng
- Cohen
- Garfinkel
- Hammond
- Higgins
- Hocott
- Johnson
- Kidokoro
- Kirman
- Kuhn
- Lebowitz
- Loring
- Morse
- Pierce
- Stout
- Surgeon General
- Tager
- Turino
- Date Loaded
- 07 Jan 1999
- Master ID
- 03607523/8364
- 03607523-8364 Comprehensive Smoking Prevention Education Act of 810000 Hearing Before the Committee on Labor and Human Resources United States Senate Ninety-Seventh Congress Second Session on S. 1929
- 03607531-7540 97th Congress 1st Session S. 1929 to Amend the Public Health Service Act and the Federal Cigarette Labeling and Advertising Act to Increase the Availability to the American Public of Information on the Health Consequences of Smoking and Thereby Improve Informed Choice, and for Other Purposes.
- 03607587-7594 National Institute on Drug Abuse Technical Review on Cigarette Smoking As An Addiction
- 03607618-7620 Coaliion on Smoking or Health Seeks to Influence Legislators
- 03607621-7623 Coalition on Smoking or Health .. A Public Policy Project with the National Interagency Council on Smoking and Health
- 03607624-7626 Former Ftc Counsel to Staff Coalition on Smoking or Health
- 03607627-7629 Statement of the American Lung Association to the House Subcommittee on Health and the Environment on H.R. 5653, the Comprehensive Smoking Prevention Education Act
- 03607630-7636 the Importance of the Federal Government in the Prevention of Smoking Related Diseases Testimony in Support of H.R. 5653, A Revised Version of H.R. 4957 the Comprehensive Smoking Prevention Education Act by the American Lung Association
- 03607681-7692 Lung Cancer, Coronary Heart Disease and Smoking
- 03607705-7710
- 03607717-7724 Statement on S. 1929 'comprehensive Smoking Prevention Education Act of 810000' of Dan G. Mcnamara, M.D., F.A.C.C. President to Honorable Orrin G. Hatch Chairman Committee on Labor and Human Resources
- 03607725-7726 File No. 792-3204
- 03607727-7730 Statement of the American Medical Association to the Labor and Human Resources Committee U.S. Senate Re: S. 1929 Comprehensive Smoking Prevention Education Act
- 03607731-7734 Statement on S. 1929 the Comprehensive Smoking Prevention Education Act of 810000 by John R. Walton, Rrt President
- 03607735-7740 Statement of the American College of Physicians on S. 1929, the 'comprehensive Smoking Prevention Education Act of 810000'
- 03607741-7749 Testimony of the American College of Chest Physicians Submitted by Thomas L Petty, M.D., F.C.C.P. President Regarding S. 1929 'the Comprehensive Smoking Prevention Education Act of 820000'
- 03607750-7751 Testimony of Action on Smoking and Health (Ash), by Its Executive Director and Chief Counsel, John F, Banzhaf III, Before the Senate Committee on Labor and Human Resources, Chaired by the Honorable Orrin G. Hatch, on the Comprehfnsive Smoking Prevention Education Act (S. 1929) Submitted 820402
- 03607752-7763 Federal Trade Commission Staff Report on the Cigarette Advertising Investigation
- 03607764-7770 Statement of the Bakery, Confectionery & Tobacco Workers International Union to the Senate Committee on Labor and Human Resources Re: S. 1929 'the Comprehensive Smoking Prevention Education Act of 820000
- 03607791-7793 Cigarette Smoking of Pregnant Women
- 03607794-7809 Peter L. Berger
- 03607810-7813 Gilgamesh on the Washington Shuttle
- 03607814-7848 Statement Rodger L. Bick, M.D.
- 03607849-7854 Statement of Theodore H. Blau Ph.D. Presented Before Subcommittee on Health and the Environment House of Representatives
- 03607855-7858 Statement of Walter M. Booker, Ph.D.
- 03607859-7864 Statment Smoking and Fetal Growth
- 03607865-7873 Curriculum Vitae Oliver Gilbert Brooke
- 03607874-7884 Statement of Barbara B. Brown, Ph.D.
- 03607885-7892 Statement of Dr. Victor Buhler
- 03607893-7896 Statement of Jack Matthews Farris, M.D.
- 03607897-7909 Statement of Sherwin J. Feinhandler, Ph.D.
- 03607910-7936 Statement of Edwin R. Fisher, M.D.
- 03607937-7945 Statement of H. Russell Fisher, M.D.
- 03607946-7979 Statement of Jean D. Gibbons
- 03607980-7983 Statement of Katherine Mcdermott Herrold, M.D.
- 03607984-7997 Statement of Arthur Furst, Ph.D.
- 03607998-8015 Statement of Richard J, Hickey, Ph.D.
- 03608016-8021 Statement of Duncan Hutcheon, M.D., D.Phil. Departments of Pharmacology and Medicine 820312
- 03608022-8053 Statement of Leon O. Jacobson
- 03608054-8065 State Ment of Lawrence L, Kupper, Ph.D.
- 03608066-8085 Statement of Hiram Thomas Langston M.D. Clinical Professor of Surgery (Emeritus) Northwestern University Medical School
- 03608086-8091 the Alleged Cost of Cigarette Smoke
- 03608092-8121 Statement of Eleanor J. Macdonald Professor Emeritus of Epidemiology Department of Cancer Prevention University of Texas System Cancer Center M.D. Anderson Hospital and Tumor Institute, Houston, Texas
- 03608122-8129 Statement of John E. O'toole, Chairman, Foote, Cone & Belding Communications, Inc.
- 03608130-8166 Statement by L.G.S. Rao, Ph.D. Bellshill Maternity Hospital Bellshill, Scotland, U.K. Regarding H.R. 4957 S. 1929
- 03608167-8169
- 03608170-8173 Statement of Henry Rothschild, M.D., Ph.D.
- 03608174-8176
- 03608177-8190 Statement of Bernice C. Sachs, M.D., Seattle, Washington
- 03608191-8195 Concerning the 'comprehensive Smoking Prevention Act of 820000'
- 03608196-8204
- 03608205-8236 Statement of Sheldon C. Sommers, M.D.
- 03608237-8246 Statement Professor T.D. Sterling
- 03608247-8275 Statement of Professor Yoram J. Wind for Submission to the Subcommittee on Health and the Environment
- 03608276-8277 for Use at 10 A.M. Tuesday, 820316
- 03608278-8287 Statement of Robert Casad Hockett
- 03608288-8317 Relationships Between Family Smoking Habits, Individual Differences in Personality, and the Smoking Behavior of College Students
- 03608318-8337 Personality and Smoking Behavior
- 03608338-8364 on the Relation Between Family Smoking Habits and the Smoking Behavior of College Students
Related Documents:
Document Images
248
Comments on H. R. 4957 -- Proposed
S. 1929
"Comprehensive Smoking Prevention Education Act of 1981"
Domingo M..Aviado, M. D.
President, Atmospheric Health Sciences, Inc.
P. 0. Box 307, Short Hills, New Jersey 07078
Adjunct Professor of Pharmacology
University of Medicine and Dentistry of New Jersey
Consultant and Former Member of the
Clean Air Scientific Advisory Committee,
Environmental Protection Agency
The proposed bill, H.R. 4957, states that "Congress finds that
... smoking is the major cause of chronic obstructive lung
diseases such as emphysema" (Section 2 (2)]. The statement
paraphrases one sentence in the introduction of the Chapter on
non-neoplastic bronchopulmonary diseases of the 1979 Report of
the Surgeon General on Smoking and Health, which reads
'cigarette smoking is the most important cause" (1).
a careful examination of the chapter raises questions about the
validity of that statement because of the complexity of the
causation of chronic obstructive lung diseases in general and
of pulmonary emphysema in particular. Although there are a
multiplicity of suspected pathogenic mechanisms and of
etiologic factors, the Surgeon General's Report refers only to
those relating to cigarette smoking with an incidental
discussion of outdoor pollution, indoor pollution, infections
Lung Diseases, March 5, 1982
249
and familial or genetic predisposit.
submission intends to discuss
investigations and those of others c
that smoking is either "the major
cz
cause" of chronic obstructive lunc
reasons are as follows:
(a) Animal experiments have
pulmonary emphysema from 1
cigarette smoke, although
successfully done so for su
oxides and other inhalants.
(b) Functional and histopath
humans show uncertain and in
cigarette smoking that do not
relationship between ciga
chronic obstructive lung dise
(c) Epidemiologic stud
association of chronic obs
several risk factors, such as
and indoor pollution, a

Lung Diseases, March 5, 1982 Page 2
t
g I
n
s
s
e
e
d
a
f
1
I
s
and familial or genetic predisposition. The author of this
submission intends to discuss his personal research
investigations and those of others questioning the conclusion
that smoking is either "the major cause" or "the most important
cause" of chronic obstructive lung diseases. Briefly, his
reasons are as follows:
(a) Animal experiments have failed to reproduce
pulmonary emphysema from long-term exposure to
cigarette smoke, although this has been
successfully done so for sulfur oxides, nitrogen
oxides and other inhalants.
(b) Functional and histopathological studies in
humans show uncertain and inconsistent effects of
cigarette smoking that do not support the -causal
relationship between cigarette smoking and
chronic obstructive lung disease.
(c) Epidemiologic studies suggest the
association of chronic obstructive disease with
several risk factors, such as levels of outdoor
and indoor pollution, alcohol consumption,

250
Lung Diseases, March 5, 1982
Page 3
occurrence of previous infections, familial
predisposition and genetic susceptibility.
A. Exverimental Animal Studies on
Pulmonarv Emohvsema.
From 1948 to 1977, the author and his colleagues
conducted smoking-related research at the University of
Pennsylvania School of Medicine where he was a Professor of
Pharmacology. The nature of this investigation was guided in
part by comments in
the 1964 Surgeon General's Report on
Smokina and Health which
suggested the need for definitive
data on the relationship between cigarette smoking and
auInb,,:rww ;?.I. ...;J.thcuVtb p.5-ght A°
the z.uxhor's
publications were mentioned in the 1967, . 1968, 1969 and 1971
Surgeon General's Reports, the coverage was brief and out of
co ntext (3-6). Over thirty of his articles on cigarette
smoking and over a hundred articles published in the 1970's on
related subjects were not mentioned.The government writers
cannot be criticized entirely, however, because they have been
examining only "Smoking and Health" rather than conducting a
global review of all suspected risk factors of chronic
obstructive lung diseases. Yet this isolated emphasis on one
Y
Lung Diseases, March 5, 1982
251
factor has limited the usefulness of
scientific documents.
a. ExDerimental Pulmonary E
1981 report of the Surgeon Genera
nopublished studies that acceptably
that the development of emphysem.
smoking. ... One study in which dog.
through chronic tracheotomies re-
emphysema [Auerbach, Hammond, Rirr
(1967)). The lesions were not con(
not been confirmed by others.
The initial series of studie:
and his colleagues dealt with the e:
cbgs (6-17). These studies failed tcl
cigarette smoke caused pulmonary e
not surprising that there has been nc
study reporting the development of
should be noted that the
single
questioned in the 1981 Surgec
h'-ghlighted in earlier Reports (inclu
been responsible for the impressio
an established cause of pulmonary emp
95-077 0-82--17

I
251
Lung Diseases, March 5, 1982 Page 4
factor has limited the usefulness of Surgeon General Re?crts as
scientific documents.
a. ExDerimental Pulmonarv Emnhvsema in the Doc. The
1981 report of the Surgeon General (7) states that "there are
nopublished studies that acceptably show in an animal model
that the development of emphysema is induced by cigarette
smoking. ... One study in which dogs received smoke directly
through chronic tracheotomies reported the development of
emphysema (Auerbach, Hammond, Kirman, Garfinkel and Stout
(1967)]. The lesions were not conclusive and the results have
not been confirmed by others.'
The initial series of studies conducted by the author
and his colleagues dealt with the effects of cigarette smoke in
dogs (8-17). These studies failed to show that inhalation of
cigarette smoke caused pulmonary emphysema. It is therefore
not surprising that there has been no confirmation of a single
study reporting the development of experimental emphysema. It
should be noted that the single positive study, although
questioned in the 1981 Surgeon General's Report, was
highlighted in earlier Reports (including 1979) and may have
been responsible for the impression that cigarette smoking is
an established cause of pulmonary emphysema.
95-077 0-82--17

Lung Diseases, March 5, 1982 Page 5
b. Exoerimental ?ulmonarv Emai:vsema in the Rat. In
1967, the author and his collaborators developed an
experimental model for producing pu lmonary emphysema in rats
(18). Unlike other models reported
permitted functional measurements in addition
histopathologic observations signifying pulmonary emphysema.
The exposure of animals to cigarette smoke did not cause
pulmonary emphysema (19). Other investigators have also used
the same model and have confirmed essentially its acceptability
for the study of pulmonary emphysema.
c. Exaerimental Pulmonary Emohvsema in the Mouse.
In 1974, the author and his collaborators developed a technique
for measuring lung function in the mouse that could not be
performed previously (20-22). Chronic exposure to cigarette
smoke simulating the dosage of smokers did not cause pulmonary
changes signifying emphysema. It is a disappointment to the
author that the only study comparing high and low nicotine
cigarettes on pulmonary function of mice was overlooked in the
1981 Report of the Surgeon General entitled The Changing
Cigarette (7). It is possible that the study was ignored
.because of the unexpected observations that the lungs seem to
adapt to repeated exposure of cigarette smoke.
Lung Diseases, March 5, 1982
253
d. ComDarative Studies with ~
rats and mice are useful experimental
toxicity of air pollutants. Animals expc
products of fuel combustion show imF
pathological lesions characteristic of pL
bronchitis. The studies are describe
Criteria Documents that have " beer
Environmental Protection Agency on o2
oxidants (23), nitrogen oxides (24) ar
particulates (25). This author questic
cigarette smoke "the major use" of pu:
primary air pollutants have been shc
emphysema in experimental animals, and G
cigarette smoking has not.
B. Human Studies on Pulmonary :
Histopathologic Changes in Cigare
The Chapter on chronic obstructi,
1979. Surgeon General's Report (pages
defining the terms chronic bronchitis an(
For each definition, there is a
structural or pathological alterations si

253
Lung Diseases, March 5, 1982 Page 6
d. Comoarative Studies with Air Pollutants. Dogs,
rats and mice are useful experimental models for the study of
toxicity of air pollutants. Animals exposed to low levels of
products of fuel combustion show impaired lung function and
pathological lesions characteristic of pulmonary emphysema and
bronchitis. The studies are described in the new series of
Criteria Documents that have been prepared by the
Environmental Protection Agency on ozone and photochemical
oxidants (23), nitrogen oxides (24) and sulfur oxides with
particulates (25). This author questions the logic of finding
cigarette smoke "the major use" of pulmonary emphysema when
primary air pollutants have been shown to cause pulmonary
emphysema in experimental animals, and with the same models,
cigarette smoking has not.
B. Human Studies on Pulmonary Function and
Histoaatholoaic Changes in Cigarette Smokers.
The Chapter on chronic obstructive lung diseases in the
1979. Surgeon General's Report (pages 6-7 to 6-52) starts by
defining the terms chronic bronchitis and pulmonary emphysema.
For each definition, there is a positive statement on
structural or pathological alterations such as hypertrophy of

255
mucous secreting apparatus and epithelial metaplasia as well as
more classic histopathological evidence of inflammation for
bronchitis; and abnormal enlargement of the air spaces distal
to the terminal nonrespiratory bronchiole accompanied by
destructive changes of the alveolar walls for emphysema.
These definitions are completely ignored in the
changes and enzymatic contents are regarded as pathological or
adverse signs of chronic bronchitis or pulmonary emphysema.
The definition of adverse and nonadverse effects has been
vigorously debated in recent years by the National Academy of
Sciences (26) and the World Health Organization (27, 28). The
National Academy of Sciences defines adverse effects as
responses that are irreversible; the reversible effects are
regarded as adaptation or defense mechanism of the lung in
response to the inhalant. The predominant opinion is to
establish irreversibility as a prerequisite to the definition
of an adverse effect. In terms of tobacco use, most of the
functional effects described in the 1979 Surgeon General's
Report are reversible, not adverse in nature, and are
indicative of physiological and biochemical adaptation of the,
lungs. . - I
Lung Diseases, March 5, 1982
a. ResDiratorv svmotoms and
chanaes. The section on the natu:
obstructive lung disease (pages 6-10 tc
qualifying statement that pathologic
specific and sensitive parameters
r
emphysema or chronic bronchitis. It
"the relationship of early respiratory
development of lung disease is unclear
studies demonstrating that individuals w
small airways function are at greater r
unavailable". Respiratory symptoms and :
tests therefore are not necessarily
effects or pathological processes. --
That smokers show abnormal lung
":
uniformly observed. In addition to a si
the Surgeon General's Report, t-here are f
during the late 1970's that were not cite
b. Clearance Mechanisms.
mucociliary transport (page 6-32) i
selective citations
from the literatu
aspects of cigarette smoking, and or,
results. Articles that show smoking
clearance in humans have been omitted.

255
Lung Diseases, March 5, 1982 Page 8
a. Resoiratorv svira*_o^.s and oulmonarv functional
chanaes. The section on the natural history of chronic
obstructive lung disease (pages 6-10 to 6-11) ends with the
qualifying statement that pathological data are the most
specific and sensitive parameters relating to pulmonary
emphysema or chronic bronchitis. It is further stated that
"the relationship of early respiratory symptoms to subsequent
development of lung disease is unclear' and that "longitudinal
studies demonstrating that individuals with abnormal tests of
small airways function are at greater risk for lung disease are
unavailabie'. Respiratory symptoms and small airway functional
tests therefore are not necessarily indicators of adverse
effects or pathological processes.
That smokers show abnormal lung -function-has not been
uniformly observed. In addition to a single study mentioned in
the Surgeon General's Report, tZiere are five other publications
during the late 1970's that were not cited (29-33).
b. Clearance Mechanisms. The discussion of
mucociliary transport (page 6-32) is another example of
selective citations from the literature showing negative
aspects of cigarette smoking, and omission of conflicting
results. Articles that show smoking accelerates bronchial
clearance in humans have been omitted. The studies of Albert
q
I
0

256
Lung Diseases, March 5, 1982 Page 9
et al on accelerated clearance in donkeys have been cited, but
their article on human clearance stimulation in smokers (34)
has been omitted, thus giving readers the impression that the
phenomenon has only been seen in donkeys.
Camner, who pioneered in clearance studies in man and
whose technique has been adapted by many clinical pulmonary
physiologists, has been overlooked. The basic concept that has
evolved from Camner's work is that adrenergic stimulation
increases mucociliary transport (35), an effect to be expected
from cigarette smoking. Patients with predominant pulmonary
emphysema but withcut chronic bronchitis are reported to have
no impairment of mucociliary transport (36). Therefore, it is
unlikely that smoking, by accelerating airway clearance, would
contribute to the paEfiogenesis bf emyphysema.
c. Proteolytic lung damace. The hypothesis that
cigarette smoke causes a protease-antiprotease imbalance and in
turn potentially leads to pulmonary emphysema is based on a
group of selected observations. There is no discussion as to
why the hypothesis has not been generally accepted. Turino
(37), the first researcher to show that proteolytic enzymes_
influence the pulmonary mechanics in vivo, has noted flaws in
the hypothesis that emphysema is caused by the imbalance of
protease and antiprotease:
257
Lung Diseases, March 5, 1982
"An inconsistency for the prim
alteration as a mechanism fo-
emphysema has been a failu:
alterations in elastin contei
human emphysema. Morphologica:
have appeared disrupted and c
data from human lungs (Johnson
Pierce and Eocott 1960; anc
with the exception of that of F
(1958), have shown no reduc
elastin content by gravimetric
The above coaiments can be reinforced by
of Kuhn et al (38) that hamsters
intratracheally and developing emphy
elastin content. Even lung fluid
smokers and nonsmokers showed no di.
enzyme content (38a).
C. Ecidemiologic StudiE
Increased mortality from pulr
chronic bronchitis
among smokers
cor.

257
Lung Diseases, March 5, 1982 Page 10
"An inconsistency for the primary role of elastin
alteration as a mechanism for inducing pulnonary
emphysema has been a failure to demonstrate
alterations in elastin content or composition in
human emphysema. Morphologically, elastin fibers
have appeared disrupted and diminished, yet most
data from human lungs (Johnson and Andres 1970;
Pierce and Hocott 1960; and Pierce et al 1961)
with the exception of that of Briscoe and Loring
(1958), have shown no reduction of parenchymal
elastin content by gravimetric techniques."
The above comments can be reinforced by the 1976 observations
of Ruhn et al (38) that hamsters treated with elastase
intratracheally and developing emphysema also show normal
elastin content. Even lung fluid samples collected from
smokers and nonsmokers showed no difference in proteolytic
enzyme content (38a).
C. Epidemiologic Studies.
Increased mortality from pulmonary emphysema and/or
chronic bronchitis among smokers compared to nonsmokers is
